Risks lead doctors to prescribe fewer pain meds
“Siff said legal liability concerns also played a role in his decision to discourage patient use of Celebrex and Bextra. Merck & Co. already is facing litigation over Vioxx.
‘Many of the things we do we do to protect ourselves from being sued,’ Siff said.”
So true. The data is still preliminary (and in the case of Naproxen, not even statistically significant), but the fear of litigation will have physicians shying away from COX-2s.
